Delivery Order SPE2DB22D9353-SPE2DB25FX2BV
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $18,488.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets. The contract, which became effective on August 1, 2025, with an ultimate completion date of August 4, 2025, was issued without set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger single-award...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $19,316.57 by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Trikafta 100-50-75 mg/75 mg packets in quantities of 14. This firm fixed-price delivery order, with an ultimate completion date of July 22, 2025, was issued without a set-aside designation. The contract represents a continuation of DMS Pharmaceutical...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $36,976.24 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The contract, issued on August 6, 2025, with an ultimate completion date of August 7, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $36,976.24 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The delivery order, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a discrete fulfillment under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for Trikafta 100-50-75 mg/75 mg packets in quantities of 14. This firm fixed-price delivery order, valued at $37,804.69, was issued on July 28, 2025, with an ultimate completion date of July 29, 2025. The award carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing...
- The Defense Logistics Agency awarded a $77,266.28 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Trikafta 100-50-75 mg/75 mg packets in quantities of 14, with an ultimate completion date of April 25, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order will be fulfilled from the company's Park Ridge facility. This award is issued under DMS...
- The Defense Logistics Agency awarded a delivery order valued at $18,488.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The award was issued on July 22, 2025, with an ultimate completion date of July 23, 2025, under a firm fixed-price contract type with no set-aside designation. This delivery order represents a discrete purchase from DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $18,488.12 by the Defense Logistics Agency on September 18, 2025, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The contract utilizes firm fixed-price pricing and carries an ultimate completion date of September 19, 2025. This award was made without a set-aside designation, allowing DMS Pharmaceutical Group to...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $18,488.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The award, issued on June 6, 2025, with an ultimate completion date of June 9, 2025, carries no set-aside designation. DMS Pharmaceutical Group will perform this delivery order from its Park Ridge, Illinois...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order valued at $18,488.12 for Trikafta 100-50-75 mg/150 mg oral units (84-count). This firm fixed-price delivery order, issued on May 6, 2025, with an ultimate completion date of May 7, 2025, represents a direct fulfillment of pharmaceutical supply needs under the company's existing Indefinite Delivery Contract with DLA. The award...
- SPE2DB22D9353Indefinite Delivery Contract
- SPE2DB22D9353-SPE2DB25FX2BVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $19,314.19 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 80-40-60mg/59.5mg packets in quantities of 14. The contract is firm fixed-price with no set-aside designation, and is scheduled for ultimate completion by August 13, 2025, one day after the award date of August 12, 2025. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, which is valued at $499,999,999 and extends through November 2026. DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, providing prescription medications, biologics, and medical consumables to Department of Defense healthcare facilities nationwide. The company has established itself as a dependable vendor through consistent contract performance delivering an extensive portfolio of pharmaceutical products ranging from contraceptive devices to oncology treatments and specialized medications. Trikafta, a cystic fibrosis treatment, represents one of many branded pharmaceutical products the company distributes to military health facilities through its indefinite delivery vehicle with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.3k | 8/12/25 |